StockNow
Calendar
Log in
U.S. Markets

Eli Lilly (LLY) says 7 out of 10 patients are choosing its obesity medicines through the government’s Medicare programme, according to a presentation

ORIGINAL · NewsquawkEli Lilly (LLY) says 7 out of 10 patients are choosing its obesity medicines through the government’s Medicare programme, according to a presentation
StockNow breaking-news AI analysis

A breaking-news item reports a 7-out-of-10 figure for patients choosing Lilly obesity medicines through Medicare, but does not define the measure or identify the presenter.

1 stocks
LLYEli Lilly & Co.$1,352.00Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US President Trump is reportedly seriously considering resuming military strikes against Iran shortly after the US midterms if diplomacy fails, while the US remains engaged in negotiations over a temporary peace deal, Semafor reports

Geopolitics

Iran's IRGC Navy claims three tankers struck naval mines, exploded and caught fire while travelling through an unauthorised southern route of the Strait of Hormuz over the past 24 hours, with the vessels subsequently abandoned

U.S. Markets

[MARKET UPDATE] Alphabet (GOOGL) -10.6% and Microsoft (MSFT) +4% in the pre-market following results

GOOGLGOOGMSFT